Drug Trial Radar · NCT03488563
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Last checked: Nov 19, 2026Latest source record: Oct 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
313
Actual
Start
Mar 30, 2018
Primary completion
Jun 17, 2019
Study completion Jul 16, 2019
Sponsor
- Lead sponsor
- AOBiome LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Veristat, Inc.
- First posted
- Apr 5, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a prospective, randomized, vehicle-controlled, double-blind, multi-center study assessing the safety, tolerability, and efficacy of B244 delivered as an intranasal spray for preventive treatment in subjects with episodic migraine.
Conditions
- Migraine
Interventions
B244Biological
B244 Suspension
VehicleBiological
Vehicle Suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0Time frame: Baseline to Day 112
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Baptist Health Center for Clinical Research
Little Rock, Arkansas
Collaborative Neuroscience Network, LLC
Long Beach, California
CI Trials
Riverside, California
Neurological Research Institute
Santa Monica, California
New England Institute for Neurology and Headache (NEINH)/Medical Practice
Stamford, Connecticut
Clinical Neuroscience Solution, Inc
Jacksonville, Florida
Precision Clinical Research
Lauderdale Lakes, Florida
Clinical Neuroscience Solution, Inc
Orlando, Florida
Palm Beach Research
West Palm Beach, Florida
Neurostudies Clinical Research
Decatur, Georgia
BTC of New Bedford
New Bedford, Massachusetts
MedVadis Research
Watertown, Massachusetts
Altea Research Institute
Las Vegas, Nevada
Rochester Clinical Research INC
Rochester, New York
PMG Research of Wilmington
Wilmington, North Carolina
CTI Clinical Research Center
Cincinnati, Ohio
Coastal Carolina Research Center
North Charleston, South Carolina
Clinical Neuroscience Solution, Inc
Memphis, Tennessee
FutureSearch Trials of Neurology and Sleep Lab, L.P.
Austin, Texas
FutureSearch Trials of Dallas, L.P.
Dallas, Texas
Texas Center for Drug Development
Houston, Texas
Charlottesville Medical Research
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.